Funded Tech Companies

Dekkun

Operating out of Cambridge, Dekkun is venture-backed, with investment from HealthCare Ventures and private investors.

Company Overview

Company Name
Dekkun
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
55 Cambridge Pkwy. 102
Cambridge, MA 02142
USA
Email Address
Not Recorded

Company Background Information

Overview
DKN-01, which targets the Dickkopf-1 (DKK-1) protein, is an inhibitor of the canonical Wnt/ß-catenin signaling pathway. DKN-01 is presently being studied in Phase 1 clinical trials in tumors which have been linked to elevated circulating levels of DKK-1 or osteolytic bone disease, including non-small cell lung cancer and multiple myeloma.
Profile
Dekkun LinkedIn Company Profile
Social Media
Dekkun Company Twitter Account
Company News
Dekkun News
Facebook
Dekkun on Facebook
YouTube
Dekkun on YouTube
Last Transaction
9/30/2012

Financing History

Date
Type
Amount
Venture Equity
$3,500,000
Venture Equity
$9,930,400


Management Team

Title
Name
Email & Social
Chief Medical Officer
Steven Landau
  Steven Landau LinkedIn Profile  Steven Landau Twitter Account  Steven Landau News  Steven Landau on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Dekko | Dekrypt Capital

 

Share this article

 


About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary